Huawei Mate 30 is still a quarter away from its official launch but it seems like we’re gonna see it’s lite version’s launch by next month.
An invitation image of Huawei Maimang 8 has now appeared on Weibo, showing the phone with waterdrop notch display to house a selfie camera and on the back, it has triple rear camera setup similar to Huawei P20 Pro but instead of an optical fingerprint, it features a physical fingerprint sensor.
The invitation clearly mentions the name as “Maimang 8” and labeled with Maimang logo on the back of the phone, which is known as Mate series’s lite phones overseas.
The launch date of Maimang 8 (Mate 30 Lite) is slated for June 5, 2019, in China but it’s not been confirmed officially by the company. Also, the company is the first contender to come with Kirin 720 processor but currently, there’s no confirmation on that as well.
Huawei opens new store in Saudi Arabia
On January 31, 2023, Huawei opened its new store at Jeddah Park in Saudi Arabia, as this counts as the second Experience store in the country with an opportunity for customers to get their favorite Huawei device.
Last year, Huawei launched its largest overseas flagship store in Saudi Arabia’s Riyadh, which expands over 2000 square meters with a minimalist design and provides a full-scenario experience to consumers.
Compared to that, the new Huawei store is expanding to 600 square meters and offers customers the to experience various technologies. These include devices such as smartphones, tablets, notebooks, wearables, and more.
According to the information, Huawei is also running offers and massive discounts for people who’ll visit the store from January 31 to February 4th, 2023.
Eric Yang, chairman and CEO of Huawei Tech Investment Saudi Arabia, said the new store in Jeddah reflects Huawei’s willingness to expand its business in the kingdom as well as its continued commitment to this strategic market.
Huawei will build first digital robot for pharmaceutical industry
Huawei will build the industry’s first digital robot with China’s National Pharmaceutical Group, Sinopharm for the pharmaceutical industry. This is a brand new progress made by the Chinese tech maker to advance its growth in digital robot technologies.
In 2019, Sinopharm began to explore digital robot technology. Several subsidiaries have implemented more than 200 business processes. There are problems such as scattered business scenarios, the inability to share robot resources, and inconsistent business processes. In order to solve some problems in the early testing, open up resource sharing, unify and optimize business processes, and realize the digitalization of deep integration of operations and business.
In 2022, Sinopharm joined hands with Huawei’s digital robot team and Huawei partners. This partnership focuses on key points such as customers, data, and business elements, sorted out the business process, and planned and built the first digital robot competence center platform in the domestic pharmaceutical industry.
Relying on the large-scale application capabilities of Huawei’s WeAutomate digital robots and mature product capabilities, Sinopharm has built a digital robot capability center platform that can meet the automation application needs of thousands of subsidiaries of the group.
After the launch, all subsidiaries of Sinopharm Holdings can share common tech in business processes, and share digital robot resources in a unified and intensive manner. In addition, the Sinopharm Digital Robotics Competence Center can fully support the group’s common situations and the personalized scenarios of the branch companies.
The common scene process is uniformly constructed by the headquarters and can be used by all branch companies. On the other hand, the custom scene process is customized and shared by the branch companies.
In the future, Huawei’s WeAutomate digital robot will continue to provide technological advantages and help Sinopharm to promote more general scenarios of digital robots to all sub-companies. On the basis of realizing the sharing of digital robot resources, it will simultaneously leverage the innovation capabilities of branch companies to meet business needs.
The process of implementing Huawei’s digital robots is also a process of normalizing and standardizing the general scenarios of branch companies, which promotes the optimization and unification of Sinopharm’s business processes. After the launch of the Sinopharm Digital Robotics Competence Center, the efficiency of the online robot business scenarios can be increased by up to 25 times, and the average efficiency can be increased by more than 10 times, effectively releasing digital momentum.
Sinopharm Holdings Co., Ltd. was established in Shanghai in January 2003 and listed in Hong Kong in September 2009. It includes two A-share listed companies, Sinopharm Group Pharmaceutical Co., Ltd. and Sinopharm Accord Pharmaceutical Co., Ltd., with a total of more than a thousand subsidiaries.
Now it has become a leading distributor and retailer of pharmaceuticals, healthcare products, and medical devices in China, as well as a leading supply chain service provider. Sinopharm ranks 22nd among Fortune China’s Top 500 in 2021.
Huawei Kirin and HarmonyOS appears in Chinese study syllabus
According to the inputs coming from Weibo, Huawei Kirin, HarmonyOS operating system and other self-developed Huawei technologies appeared in the study test syllabus question book.
A picture shared online shows questions that have carried out an inventory of the product names of China’s most influential technology companies. And said that these product names are very distinctive, including the mobile chipset “Kirin”, the operating system “HarmonyOS”, the server chip “Kunpeng” and more.
The latest appearance of these popular technologies is the result of the people behind the development that put countless hours to bring them into reality.